Skip to Content

Rabies vaccine, human diploid cell Pregnancy and Breastfeeding Warnings

Rabies vaccine, human diploid cell is also known as: Imovax Rabies

Rabies vaccine, human diploid cell Pregnancy Warnings

This drug should not be used during pregnancy unless the benefit outweighs the risk to the fetus. AU TGA pregnancy category: B2 US FDA pregnancy category: C Comments: -If there is substantial risk of rabies exposure, pre-exposure prophylaxis may be indicated. -Because of the consequences of inadequately treated rabies exposure, pregnancy is not a contraindication to post-exposure prophylaxis.

Animal studies have not been conducted. There are no controlled data in human pregnancy. Limited data have not shown fetal abnormalities with rabies vaccination. AU TGA pregnancy category B2: Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed. Studies in animals are inadequate or may be lacking, but available data show no evidence of an increased occurrence of fetal damage. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Rabies vaccine, human diploid cell Breastfeeding Warnings

Caution is recommended; benefit to mother should outweigh risk to the infant. Excreted into human milk: Unknown Excreted into animal milk: Data not available

See references

References for pregnancy information

  1. Cerner Multum, Inc. "Australian Product Information." O 0
  2. "Product Information. Imovax Rabies (rabies vaccine, human diploid cell)." sanofi pasteur, Swiftwater, PA.

References for breastfeeding information

  1. "Product Information. Imovax Rabies (rabies vaccine, human diploid cell)." sanofi pasteur, Swiftwater, PA.
  2. Cerner Multum, Inc. "Australian Product Information." O 0

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.